Thromboembolism in Patients With the 'Lupus'-Type Circulating Anticoagulant

作者: Mazen Elias

DOI: 10.1001/ARCHINTE.1984.00350150102029

关键词: Venous thrombosisStrokeGastroenterologyMedicineCirculating anticoagulantExcessive BleedingLupus anticoagulantIn patientSystemic lupus erythematosusThrombosisInternal medicineSurgery

摘要: • Thirty-five patients with the lupus anticoagulant (LA) were followed up between 1975 and 1982. The most prevalent clinical manifestation occurring in these was thrombosis. Nineteen (54.3%) had a single or recurrent thrombotic episode. Fifteen (42.8%) venous thrombosis, arterial thrombosis manifested by stroke transient ischemic attacks occurred six patients. Bleeding only five patients, four of whom severe thrombocytopenia, while no excessive bleeding noted during 18 operative procedures. Various therapeutic regimens, including corticosteriods, nonsteroidal anti-inflammatory drugs, cytotoxic immunosuppressive agents, effect on presence LA Anticoagulants successful treatment prevention episodes. (Arch Intern Med1984;144:510-515)

参考文章(31)
MA Schleider, RL Nachman, EA Jaffe, M Coleman, A clinical study of the lupus anticoagulant Blood. ,vol. 48, pp. 499- 509 ,(1976) , 10.1182/BLOOD.V48.4.499.499
Pascuzzi Ca, Thompson Jh, Owen Ca, Bowie Ej, THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS. Journal of Laboratory and Clinical Medicine. ,vol. 62, pp. 416- 430 ,(1963) , 10.5555/URI:PII:0022214363900416
MOHAMMAD H ZARRABI, STANLEY ZUCKER, FREDRICK MILLER, ROBERT M DERMAN, GAIL S ROMANO, JAMES A HARTNETT, ANDRE O VARMA, Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients Annals of Internal Medicine. ,vol. 91, pp. 194- 199 ,(1979) , 10.7326/0003-4819-91-2-194
J.J. Veltkamp, P. Kerkhoven, E.A. Loeliger, Circulating Anticoagulant in Disseminated Lupus Erythematosus Pathophysiology of Haemostasis and Thrombosis. ,vol. 2, pp. 253- 259 ,(1973) , 10.1159/000214029
ALVIN MARGOLIUS, DUDLEY P. JACKSON, OSCAR D. RATNOFF, Circulating anticoagulants: a study of 40 cases and a review of the literature. Medicine. ,vol. 40, pp. 145- 202 ,(1961) , 10.1097/00005792-196105000-00002
G. Remuzzi, R. Misiani, D. Muratore, D. Marchesi, M. Livio, A. Schieppati, G. Mecca, G. de Gaetano, M.B. Donati, Prostacyclin and human foetal circulation Prostaglandins. ,vol. 18, pp. 341- 348 ,(1979) , 10.1016/S0090-6980(79)80052-0
P Thiagarajan, S S Shapiro, L De Marco, Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. Journal of Clinical Investigation. ,vol. 66, pp. 397- 405 ,(1980) , 10.1172/JCI109869
Luis O. carreras, Jos Vermylen, Bernard Spitz, Andre Assche, "Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. British Journal of Obstetrics and Gynaecology. ,vol. 88, pp. 890- 894 ,(1981) , 10.1111/J.1471-0528.1981.TB02224.X
Rosa T. Canoso, Ronald A. Hutton, Daniel Deykin, A chlorpromazine‐induced inhibitor of blood coagulation American Journal of Hematology. ,vol. 2, pp. 183- 191 ,(1977) , 10.1002/AJH.2830020209